- Raised $400k grant, May 2016
- Raised funding round led by MedTech Innovator, May 2017
About
Amnis Therapeutics is a biomedical engineering company specializing in developing, manufacturing, and marketing lifesaving endovascular technologies for emergency situations. Its mission is to provide the medical community with innovative, high-performance devices that offer a reliable, proven solution for numerous endovascular indications. The companys AneugraftDx is a pericardium covered coronary stent for emergency vessel reconstruction in cases of acute rupture or dissection of a coronary artery, coronary aneurysm, or saphenous vein graft reperfusion. The AneugraftNx is a neurovascular pericardium covered stent designed specifically for intracranial indications such as aneurysms, ruptures, and cavernous carotid fistulas (CCFs). The innovative, biologically covered stents provide immediate blood vessel reconstruction in a one-step procedure. In addition to its covered stent technology, Amnis Therapeutics is expanding its product development to include other unique solutions for emergency intra-arterial interventions. The most recent of these products is the Golden Retriever, a mechanical neurothrombectomy device for the emergency treatment of acute ischemic stroke.
Funding history · 2 rounds · $400K total
Q&A
- What is Amnis Therapeutics' primary focus?
- Amnis Therapeutics is a biomedical engineering company that specializes in developing, manufacturing, and marketing lifesaving endovascular technologies for emergency situations.
- What is the status of Amnis Therapeutics?
- Amnis Therapeutics is currently inactive, having ceased operations in July 2021.
- When was Amnis Therapeutics founded?
- Amnis Therapeutics was founded in January 2007.
- What is AneugraftDx?
- AneugraftDx is a pericardium-covered coronary stent developed by Amnis Therapeutics for emergency vessel reconstruction in cases of acute rupture or dissection of a coronary artery, coronary aneurysm, or saphenous vein graft reperfusion.
- What is AneugraftNx?
- AneugraftNx is a neurovascular pericardium-covered stent from Amnis Therapeutics designed for intracranial indications such as aneurysms, ruptures, and cavernous carotid fistulas (CCFs).
- What is the Golden Retriever product?
- The Golden Retriever is a mechanical neurothrombectomy device developed by Amnis Therapeutics for the emergency treatment of acute ischemic stroke.
- How much funding has Amnis Therapeutics raised in total?
- Amnis Therapeutics has raised a total of $400,000.
- Which investors participated in Amnis Therapeutics' funding rounds?
- The Office of the Chief Scientist and MedTech Innovator participated in funding rounds for Amnis Therapeutics.
Sectors & technology
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/10584405 | |
| YouTube | youtube.com/channel/UCXvZ_dSrMa2s1FoVPbKdTwA |
Identifiers & details
| Former names | ITGI Medical |
|---|---|
| Founded | 2007-1 |
| Status reason | Non Active, Jul 2021 ceased to operate |